Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples